A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

Clinical trial NCT02186171 · COMPLETED

Trial details

NCT number: NCT02186171
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis in Men

Start date: 2014-06-16
Primary completion: 2016-02-15
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.